{"id":"W4408295760","doi":"10.3389/fonc.2025.1530391","title":"Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review","year":2025,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Palbociclib; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Clinical trial; Progression-free survival; Breast cancer; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0009217144,0.0008557533,0.01469227,0.001471088,0.00002558377,0.000002744364,0.000397835,0.0003240338,0.00007849355],"category_scores_gemma":[0.0002139021,0.0006536429,0.0007222381,0.002551504,0.00029298,0.0000850494,0.00007734985,0.0004250827,0.000003313192],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007376167,"about_ca_system_score_gemma":0.00244426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007052924,"about_ca_topic_score_gemma":0.001039414,"domain_scores_codex":[0.9935828,0.001834418,0.002896502,0.0008071465,0.0003183474,0.0005607798],"domain_scores_gemma":[0.995264,0.001300143,0.00203388,0.001031162,0.0002488782,0.0001219405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0005684742,0.0007451184,0.0003691409,0.6314984,0.001042411,0.000125819,0.00004705003,0.00004094769,6.632499e-7,0.00002098883,0.0000915994,0.3654494],"study_design_scores_gemma":[0.004962783,0.001080952,0.0002101185,0.9006593,0.007794634,0.0001381417,0.00005266094,0.00001400276,0.000008543341,0.0001295975,0.08456596,0.0003832738],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001704076,0.9866224,0.0003399222,0.0001470202,0.001048359,0.0108265,0.0005681356,0.00003691929,0.0003936861],"genre_scores_gemma":[0.00004189913,0.9900947,0.003319724,0.00005559066,0.00004774921,0.005303741,0.0003644905,0.00009259739,0.0006794709],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3650661,"threshold_uncertainty_score":0.9999356,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02307810834817388,"score_gpt":0.3946680097727225,"score_spread":0.3715899014245486,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}